Header Image: Rex Vaughn, chair of the Alabama Medical Cannabis Commission, speaking to reporters after the commission’s meeting on Dec. 11, 2025, in the Alabama State House in Montgomery, Alabama. The commission approved three dispensary licenses at its meeting on Thursday. (Anna Barrett/Alabama Reflector)
The Alabama Medical Cannabis Commission Thursday approved three dispensary licenses, which members of the commission hailed as a critical step toward making medical cannabis available in Alabama nearly five years after the Legislature established the program.
“We waited a long time to get to this point in time where we can make a decision like this, and it is monumental,” Rex Vaughn, chair of the commission, said. “It’s a milestone meeting for us, so I’m tickled we can get this far.”
GP6 Wellness, RJK Holdings and CCS of Alabama will receive dispensary licenses within 28 days, as long as the companies pay the $40,000 licensing fee. A fourth license will be approved by the commission in late January due to a recommendation from an administrative law judge, Vaughn said after the meeting.
Vaughn said multiple times during the meeting that the approval of dispensary licenses is a milestone and will lead to patients getting care they need and tax revenue for the state.
“It takes a while for that to come through the system, but we should be seeing revenue by springtime at the latest,” Vaughn said.
The Alabama medical cannabis law, enacted in 2021, allows registered physicians to recommend cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s Disease, PTSD, sickle-cell anemia, chronic pain, and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils, and gummies (only peach flavor), with raw plant material and smokable forms remaining prohibited.
People who suffer from the qualifying conditions must get approval from their physician and enter the patient registry in order to buy products at a dispensary.
Read more at
